TX05

· Tanvex BioPharma USA, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TX05, covering 2022-01-14 to 2022-01-14. Get the full timeline:

Most recent: Clinical Trial Update: Trial to Compare the Safety, Efficacy and Immunogenicity of TX05 With Herceptin® in HER2+ Early Breast Cancer [Phase 3]

See pricing